Adam Laing
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
- Immune Response and Inflammation
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
-
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 6
- Immunotherapy and Immune Responses 2
- Immune Response and Inflammation 1
-
- Signaling Pathways in Disease 2
- Melanoma and MAPK Pathways 1
- Co-authors
- Pierre Vantourout (6 shared papers)Adrian Hayday (7 shared papers)Anett Jandke (2 shared papers)Philip East (2 shared papers)Deena L. Gibbons (2 shared papers)Peter M. Irving (2 shared papers)Robin Dart (2 shared papers)Oliver Nussbaumer (1 shared paper)
- Journals
- Nature Communications (2 papers)The Journal of Immunology (1 paper)Science Advances (1 paper)eLife (1 paper)Cell (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Adam Laing
10 papers receiving 839 citations
Peers
Comparison fields: 5 of 68
- Immunology 655
- Transplantation 53
- Oncology 173
- Physiology 21
- Epidemiology 125
Countries citing papers authored by Adam Laing
This map shows the geographic impact of Adam Laing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Laing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Laing more than expected).
Fields of papers citing papers by Adam Laing
This network shows the impact of papers produced by Adam Laing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Laing. The network helps show where Adam Laing may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam Laing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 254 | |
| 2 | 2013 | 209 | |
| 3 | 2016 | 155 | |
| 4 | 2018 | 120 | |
| 5 | 2020 | 48 | |
| 6 | 2020 | 32 | |
| 7 | 2018 | 17 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 1 | |
| 11 | 2018 | 0 |
About Adam Laing
Adam Laing is a scholar working on Immunology, Molecular Biology, Oncology, Epidemiology and Pharmacology, having authored 11 papers that have together received 844 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers), Signaling Pathways in Disease (2 papers), Immunotherapy and Immune Responses (2 papers), Melanoma and MAPK Pathways (1 paper), Cell Adhesion Molecules Research (1 paper), Immune Response and Inflammation (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Immunology (655 citations), Transplantation (53 citations), Oncology (173 citations), Physiology (21 citations) and Epidemiology (125 citations). Adam Laing has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Pierre Vantourout, Adrian Hayday, Anett Jandke, Philip East, Deena L. Gibbons, Peter M. Irving, Robin Dart, Oliver Nussbaumer, Bradley Spencer‐Dene and Rafael Di Marco Barros. Their work appears in journals such as Nature Communications, The Journal of Immunology, Science Advances, eLife and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.